open access
Simultaneous choroidal melanoma and renal cell carcinoma in middle-aged patient
Affiliations- Department of Surgery (Ophthalmology), King Hussein Cancer Centre, Amman, Jordan
- Department of Pathology, King Hussein Cancer Center (KHCC), Amman, Jordan
- Department of Surgery (Uro-oncology), King Hussein Cancer Centre, Amman, Jordan
open access
Abstract
Background: Although rare, choroid melanoma is the most common intraocular malignancy amongst adults. Similarly, renal cell carcinoma (RCC) is another rare malignancy that counts for 2–3 percent of all adult malignancies. Second primary cancers are not uncommon, even though they occur less frequently than primary cancers.
Case presentation: We present a rare choroidal melanoma case in a 55-year-old adult who presented with a one-month history of the painless gradual decrease of vision. His investigations revealed a clinical diagnosis of large choroid melanoma, and upon metastatic workup, he was incidentally found to have synchronous RCC. Both malignancies were treated surgically (and the pathology confirmed the clinical diagnosis of choroidal melanoma and RCC). The patient was free of metastatic or recurrent disease at 12 months follow-up.
Abstract
Background: Although rare, choroid melanoma is the most common intraocular malignancy amongst adults. Similarly, renal cell carcinoma (RCC) is another rare malignancy that counts for 2–3 percent of all adult malignancies. Second primary cancers are not uncommon, even though they occur less frequently than primary cancers.
Case presentation: We present a rare choroidal melanoma case in a 55-year-old adult who presented with a one-month history of the painless gradual decrease of vision. His investigations revealed a clinical diagnosis of large choroid melanoma, and upon metastatic workup, he was incidentally found to have synchronous RCC. Both malignancies were treated surgically (and the pathology confirmed the clinical diagnosis of choroidal melanoma and RCC). The patient was free of metastatic or recurrent disease at 12 months follow-up.
Keywords
uveal melanoma; renal cell carcinoma; synchronous
About this articleTitle
Simultaneous choroidal melanoma and renal cell carcinoma in middle-aged patient
Journal
Issue
Vol 8 (2023): Continuous Publishing
Article type
Case report
Pages
25-28
Published online
2023-05-02
Page views
1816
Article views/downloads
386
DOI
Bibliographic record
Ophthalmol J 2023;8:25-28.
Keywords
uveal melanoma
renal cell carcinoma
synchronous
Authors
Qusai F. Abu Salim
Mona Mohammad
Jakub Khzouz
Rami Ghanem
Yacoub A. Yousef
References (16)- Finger PT. Intraocular Melanoma. In: Devita VT, Lawrence TS, Rosenberg SA. ed. Cancer (Principles & Practice of Oncology) Ophthalmology 10th ed. Wolters Kluwer 2011: 1770–1779.
- Yousef YA, Mohammad M, Al-Nawaiseh I, et al. Retinoblastoma and uveal melanoma in Jordan: incidence, demographics, and survival (2011-2020). Ophthalmic Genet. 2022 [Epub ahead of print]: 1–8.
- Shields CL, Shields JA, Gross NE, et al. Survey of 520 eyes with uveal metastases. Ophthalmology. 1997; 104(8): 1265–1276.
- Jaradat I, Zewar A, AlNawaiseh I, et al. Characteristics, management, and outcome of patients with uveal melanoma treated by Iodine-125 radioactive plaque therapy in a single tertiary cancer center in Jordan. Saudi J Ophthalmol. 2018; 32(2): 130–133.
- Zewar A, Nawaiseh I, Jaradat I, et al. Management and Outcome of Uveal Melanoma in a Single Tertiary Cancer Center in Jordan. Turk Patoloji Derg. 2016; 32(3): 186–192.
- Kujala E, Mäkitie T, Kivelä T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2003; 44(11): 4651–4659.
- Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007; 57(1): 43–66.
- Motzer RJ, Bander NH, Nanus DM, et al. Infrequent ras oncogene point mutations in renal cell carcinoma. J Urol. 1990; 143(1): 175–178.
- Choi JY, Lee KS, Kwon OJ, et al. Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging. J Clin Oncol. 2005; 23(30): 7654–7659.
- Diener-West M, Reynolds SM, Agugliaro DJ, et al. Collaborative Ocular Melanoma Study Group. Second primary cancers after enrollment in the COMS trials for treatment of choroidal melanoma: COMS Report No. 25. Arch Ophthalmol. 2005; 123(5): 601–604.
- Rheingold SR, Neugut AI, Meadows AT. Second cancers: Incidence, risk factors, and management. In: Kufe DW, Pollock RE, Weichselbaum RR. et al. ed. Cancer medicine, 6th ed. BC Decker, Hamilton, Ontario 2003: 2623–2631.
- Chin K, Finger P, Kurli M, et al. Second cancers discovered by 18FDG PET/CT imaging for choroidal melanoma. Optometry J Am Optom Assoc. 2007; 78(8): 396–401.
- Warren S, Gates O. Multiple primary malignant tumors. Surgery of literature and statistical study. Am J Cancer. 1932; 16: 1358–1414.
- McLaughlin CC, Wu XC, Jemal A, et al. Incidence of noncutaneous melanomas in the U.S. Cancer. 2005; 103(5): 1000–1007.
- Wang Z, Nabhan M, Schild SE, et al. Charged particle radiation therapy for uveal melanoma: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys. 2013; 86(1): 18–26.
- Khalil Ibrahim A. Trends of adult primary malignant renal tumors over 6 years. Pak J Med Sci. 2013; 29(6): 1385–1388.